More than 100 years ago, the discovery of the tomb of Egyptian pharaoh Tutankhamen sparked intrigue and speculation.
Contained within this ancient burial site were King Tut’s intact mummy, gold jewelry, clothing, and other artifacts preserved for his afterlife.
This significant archaeological find not only illuminated ancient Egyptian culture but also piqued curiosity about the embalming practices from 3,000 years ago.
However, the opening of the tomb also gave rise to the notorious legend of the “mummy’s curse,” which suggested that misfortune would befall anyone who disturbed the tombs of these ancient rulers.
Several members of the archaeological team faced untimely deaths, fueling the superstition that surrounded the discovery.
Later, researchers posited that the curse may have stemmed from exposure to harmful fungi present in the tomb, notably Aspergillus flavus.
This fungus produces toxic spores that can lead to lung disease and other health concerns for those who inhale them.
In a twist of fate, bioengineers at the University of Pennsylvania have now found that this same fungus may offer potential health benefits, particularly in the fight against leukemia.
Their findings were recently published in the esteemed journal, Nature Chemical Biology.
“It’s very exciting,” remarked Dr. Xue Sherry Gao, a chemical and biomolecular engineer at UPenn and the lead author of the study.
In her words, “This fungus was toxic to humans previously, and now we’re thinking about a drug application.”
The quest for medicinal applications of fungi is not entirely new.
Penicillin, commonly regarded as one of the most prevalent antibiotic drugs, is derived from a specific species of fungi.
Additionally, some statins used to manage high cholesterol also trace their origins back to fungal compounds.
Dr. Gao and her team initially sought to explore whether Aspergillus flavus could function as an antibiotic against bacterial infections or help clear other fungal infections, such as yeast infections.
However, their tests did not reveal any significant antibacterial or antifungal activity.
Undeterred, the researchers turned their focus to cancer.
“Then we’re thinking about, OK, how about cancer cells?” Gao said, signaling a pivotal shift in their research approach.
The results were promising; initial laboratory tests showed that the fungus inhibited unregulated cell division, a hallmark of cancer, specifically in leukemia cells.
To increase the efficacy of the fungus in combating leukemia, the researchers modified and engineered its fungal molecules.
In follow-up tests, they observed a remarkable enhancement in the leukemia cell-killing activity—an increase by 100-fold.
This level of effectiveness is comparable to existing anti-leukemia drugs currently available in the market.
Despite these encouraging results, Dr. Gao emphasized that these findings are still confined to controlled laboratory environments.
More comprehensive studies are necessary to determine how effectively these modified fungal compounds can eradicate cancer cells before advancing toward drug development phases, including human clinical trials.
Gao remains optimistic about the potential for these discoveries to pave the way for a new cancer therapy.
She also hopes to inspire more researchers to delve into medicinal uses of fungi, a field that remains largely underexplored.
In the end, this groundbreaking research offers a glimpse at how a fungus once steeped in superstition could find a new and beneficial place in medicine.
image source from：whyy
